Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: CAS:6893-26-1 (
glutamate
)
73,096
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Our efforts have been directed towards characterizing amino acid uptake, metabolism and release in bulk-isolated glia and neuronal perikarya studied in parallel with nerve-endings, especially as it concerns the transmitter amino acids and the participation of glia in the clearing of the synpatic space during impulse conduction. A possible neuromodulator role for the glia at the synapse is also suggested by K+-stimulated release. Our most definitive conclusions have been based so far on studies with GABA, although we are also beginning to accumulate data for
glutamate
related to
glutamate
-glutamine compartmentation. Glia preferentially accumulate potassium and amino acids compared to neuronal perikarya, have higher Na+/K+-ATPase activity, possess high-affinity, sodium-dependent uptake systems for GABA and
glutamate
similar to the ones in synaptosomes, and release amino acid in response to a potassium pulse by a calcium-independent process. Low neuronal uptake could be due to loss of dendrites. Unidirectional GABA-flux from the synaptosomal to glial compartment is supported by high
GAD
in nerve endings compared to high GABA-T in glia. Glutamine may be a transmitter
glutamate
-precursor in nerve-endings since glutaminase activity is high in nerve-endings, but low in glia where glutamine is presumably made. Glutamine uptake in both glia and synaptosomes obeys low-affinity kinetics in contrast to
glutamate
, consistent with the inability of glutamine to excite the neuronal membrane. The studies with GABA, which are considerably more extensive, are supported by related work using glia in tissue-culture and autoradiography. There appears to be a suggested difference in the behavior of amines which were poorly taken up by the glial system. Glia, synaptosomes and neuronal perikarya, in general behaved similarly with respect to requirements for uptake and release, except in the case of Ca++, which exerted opposite effects on glial and synaptosomal uptake of GABA. We believe that work along these lines tends to firmly establish a direct role for glial cells as modulators of neuronal excitability and represents a convergence between transmitter amino acid neuropharmacology and cellular biochemistry. This not only deepens and enlarges the vocabulary of synaptic biochemistry but also undoubtedly will have major clinical applications in the fields of epilepsy and behavior.
...
PMID:Amino acid transport in isolated neurons and glia. 0 26
A method of purifying the glutamate decarboxylase from human brain is described. The enzyme was purified 8 000 fold in regard to the initial homogenate and appears homogenous by electrophoresis, both in denaturing and non-denaturing conditions. The molecular weight of the native enzyme and its subunits indicate that
GAD
from human brain is formed by two similar if non identical polypeptide chains. The Km for
glutamate
and pyridoxal phosphate found for the human enzyme, respectively 1,2.10(-3) M and 0,13.10(-6) M, are close to the Km found for the Mouse enzyme.
...
PMID:[Purification of the glutamate decarboxylase from human brain]. 2 21
Glutamic acid decarboxylase (
GAD
, EC 4.1.1.15), the enzyme which catalyzes the alpha-decarboxylation of L-
glutamate
to form the neurotransmitter gamma-aminobutyric acid (GABA), was localized immunocytochemically in rat neostriatum, pallidum and entopeduncular nucleus. A large amount of
GAD
-positive reaction product was observed in both the pallidum and entopeduncular nucleus in light microscopic preparations and was localized ultrastructurally to axon terminalis that surrounded dendrites and large somata. In the neostriatum the relative numbers of
GAD
-positive axons terminals per unit area were substantially less than in the pallidum.
GAD
-positive terminals predominantly formed symmetric synapses with somata, dendrites and spines, but a small number of them formed asymmetric synapses with either dendrites or spines. The presence of
GAD
within these terminals is consistent with results of other investigations which have indicated that the striatopallidal and striatoentopeduncular pathways as well as neostriatal local circuit neurons and/or collaterals from neostriatal projection neurons, use GABA as a neurotransmitter.
GAD
-positive reaction product was also localized within the somata and dendrites of neostriatal and pallidal neurons in colchicine-injected preparations. The
GAD
-positive somata in the pallidum were medium-sized neurons and since such cells project to the substantia nigra, our results are in agreement with those from other studies which demonstrate a GABAergic, pallidonigral pathway. In the neostriatum,
GAD
-positive somata were identified light microscopically as medium-sized neurons with either round or fusiform shapes. Electron microscopic examinations also showed
GAD
-positive reaction product within the perikaryal and dendritic cytoplasm of these neurons, as well as in dendritic spines. These findings are in accord with the results of studies which have indicated that medium-sized, spinous neurons of the neostriatum give rise to a GABAergic, striatonigral pathway. The significance of
GAD
localization within these neostriatal neurons is discussed in relation to recent findings which show that substance P is contained within this same class of striatonigral projection neuron.
...
PMID:The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry. 22 67
The uptake of the inhibitory transmitter substance gamma-aminobutyric acid (GABA) into the adult rat pineal gland was studied autoradiographically using both light and electron microscopy. The sites of GABA uptake were shown to be exclusively present in the gliocyte cells of the gland following both in vitro incubation with tritiated GABA and after in vivo administration of the amino acid by intra-arterial injection. Both the pinealocyte cells and the numerous sympathetic axons in the gland were devoid of silver grains. Preliminary biochemical studies indicated that the gliocyte uptake process for GABA resembles that in the satellite glia of the sensory ganglia but differed from that in slices of the cerebral cortex. Evidence is also presented which shows the pineal gland to contain endogenous GABA and the enzymes directly associated with its in vivo metabolism, L-
glutamate
-1-carboxylase (EC 4.1.1.15) (
GAD
) and GABA-2-oxoglutarate aminotransferase (EC 2.6.1.19) (GABA-T). Furthermore, a 3-fold rise in endogenous GABA occurred in the pineal after inhibition of GABA-catabolism as would be expected if the GABA-shunt pathway was functionally active in the oxidative metabolism of the pineal gland.
...
PMID:On GABA metabolism in the gliocyte cells of the rat pineal gland. 23 81
1. Glutamic acid showed a significant decrease during hibernation in brain cortex. This is attributed to: (a) Transformation to glutamine to detoxicate ammonia. (b) The synthesis of GABA from glutamic acid. (c) It is suggested that the enzyme
GAD
is active during hibernation. 2. GABA showed a significant increase in liver and brain cortex. It was absent in the blood serum. (a) The present results show that non-neural tissues contain lower GABA than neural tissues. (b) GABA may be formed locally in tissues by decarboxylation of
glutamate
as well as from pathways connected with tricarboxylic acid cycle. 3. Aspartic acid showed increased levels in blood serum, liver and brain cortex, the greatest increase was observed in liver. 4. A significant increase was recorded in the level of arginine in brain cortex and liver, whilst a smaller percentage increase was recorded in ornithine level. It is assumed that transformation of arginine to ornithine was depressed during hibernation.
...
PMID:Metabolism of hibernating reptiles. Changes of free amino acids in blood, liver and brain. 31 10
1. The locations of the high affinity uptakes of
glutamate
, aspartate and GABA were studied autoradiographically and microchemically in slices of hippocampus and septum in vitro. 2. In hippocampus the distributions of the uptake sites for
glutamate
and aspartate were very similar, with much higher uptake in zones containing pyramidal cell terminals than in other zones. A reciprocal distribution was found for GABA uptake, which was in agreement with that of
GAD
. 3. Cutting pyramidal cell axons to CAl reduced the uptake of aspartate and
glutamate
in the target area in CAl by 80%. 4. Autoradiographically the uptake of aspartate was very high in the dorsal part of the lateral septum, moderately high in nucleus accumbens septi and neostriatum, and very low in the medial septum. GABA uptake was lower in the medial than in the lateral septum, but very high in a narrow transitional zone and in the insula Cajella magna. 5. Transecting the axons from hippocampus and subiculum to septum, gave a 70% reduction in the uptakes of aspartate and
glutamate
in the lateral septum, but no reduction in the medial septum. 6. Literature data on uptake, content and release of
glutamate
and aspartate in nerve endings in brain are briefly reviewed.
...
PMID:Tentative localization of glutamergic and aspartergic nerve endings in brain. 54 67
A synaptic vesicle fraction was prepared from calf brain cortex, containing 10 identified amino acids and two unidentified ninhydrin-positive compounds, one of which is apparently a peptide. The most plentiful amino acids were taurine (1.8 nmol/g original tissue), glutamic acid (1.8), serine (0.9), aspartic acid (0.8) and GABA (0.8); the others identified were cysteic acid (or cysteinesulphinic acid), glutamine, alanine, glycine and lysine. The unknown peptide occurred in a high concentration (about 16 alanine equivalents/g), and contained mainly aspartic acid and serine. Cysteic acid (or cysteinesulphinic acid) also occurred in relatively high amounts, but its peak contained acid-labile impurities. The influx of [14C]
glutamate
into the vesicles took place by means of non-saturable migration, while two saturable systems having very similar properties were dominant only at low
glutamate
concentrations. Influx constants for these quantitatively low uptake systems were Km, 34 and 92 micrometer, and Vmax, 33 and 49 nmol/min/g obtained by v versus v/S plot. Almost the same values were also obtained by a 1/v versus 1/S plot.
GAD
and GABA-T activities in the vesicles were only 1/200th of those in the synaptosomes.
...
PMID:Amino acids in the synaptic vesicle fraction from calf brain: content, uptake and metabolism. 58 77
L-Glutamate decarboxylase (
GAD
, EC 4.1.1.15), the enzyme which catalyzes the alpha-decarboxylation of L-
glutamate
to form gamma-aminobutyric acid (GABA), was localized both light and electron microscopically in rat substantia nigra by an immunoperoxidase method. Large amounts of
GAD
-positive reaction produce were seen throughout the substantia nigra in light microscopic preparations, and it appeared to be localized in punctate structures that were apposed to dendrites and somata. Electron microscopic studies revealed that most of the axon terminals in the substantia nigra were filled with
GAD
-positive reaction product and formed both axodendritic and axosomatic synapses. Many dendrites were extensively surrounded by
GAD
-positive terminals which most commonly formed symmetric synaptic junctions, although some formed asymmetric synpatic junctions. The results of this investigation are consistent with biochemical, pharmacological and physiological data which have indicated that neurons of the neostriatum and globus pallidus exert a GABA-mediated, postsynaptic inhibition upon the neurons of the substantia nigra. These findings provide another example in the vertebrate central nervous system where Golgi I projection neurons are inhibitory and use GABA as their neurotransmitter.
...
PMID:Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra. 78 59
Using the cytoplasmic soluble fraction from rat brain as a source of
glutamate
decarboxilase, its enzymatic activity was induced by electrical stimulation and determined by gas release. Modified Warburg's flasks were used for such determination. The limits of frequency and the use of sinusoidal waves were based on normal cerebral rhythms. At low frequencies,
GAD
activity is markedly enhanced (1-10 Hz, 2v, 500 muA). Activation of the enzyme may be due to distortion of the tertiary structure promoting thus an increased coupling between the substrate and the enzyme complex.
...
PMID:The effect of electrical stimulation upon the activity of brain glutamate decarboxilase "in vitro". 88 30
In the belief that homocysteine-induced convulsions might be related to alterations in brain gamma-aminobutyric acid metabolism, we have studied the action of this amino acid on the activity of glutamic decarboxylase (
GAD
, EC 4.1.1.15) and gamma-aminobutyrate aminotransferase (EC 2.6.1.19) of mouse brain in vitro DL-homocysteine competitively inhibited
GAD
with respect to both L-
glutamate
and pyridoxal 5'-phosphate. The respective Ki's were 3.8 mM and 0.3 mM. The activity of GABA-T also was altered in the presence of DL-homocysteine. A competitive inhibition (Ki = 6 mM) was observed with gamma-aminobutyric acid, and an uncompetitive inhibition with respect to pyridoxal 5'-phosphate and alpha-ketoglutarate. These results are explained in terms of a dual action of homocysteine on each of the enzymes: one involving a competition for substrate binding site and the other involving the formation of an inactive inhibitor-cofactor complex. The significance of the inhibition of these enzymes of gamma-aminobutyric acid metabolism is discussed in relation to the convulsant action of homocysteine.
...
PMID:The mode of action of homocysteine on mouse brain glutamic decarboxylase and gamma-aminobutyrate aminotransferase. 90 1
1
2
3
4
5
6
7
8
9
10
Next >>